ArticleJournal of health, population, and nutrition2025
Association of dietary intake of folate, serum folate, and red blood cell folate with mortality risk in patients with depression: a population-based longitudinal cohort study.
Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFolate level is associated with depression, yet prospective evidence is lacking on the relationship of dietary intake, serum, and red blood cell (RBC) folate levels with mortality risk in patients with depression.
methodsDietary intake, serum, and RBC folate data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2018 were included. Depression was diagnosed using the PHQ-9 with a cutoff value of 5. Additionally, all-cause and cause-specific mortality data up to December 31, 2019, were determined from the National Death Index. Weighted multivariable Cox regression and restricted cubic spline (RCS) analysis were used to determine the relationship between folate and outcomes.
resultsA total of 4843 adult patients with depression were included, with a mean age of 45.16 years, and females accounted for 61.59%. Over a mean follow-up of 7.2 years, 544 participants died. Weighted Cox regression showed that, after adjustment, only RBC folate among nine folate indicators significantly predicted all-cause mortality in patients with depression. A per standard deviation (SD) increase in RBC folate increased the all-cause mortality risk by 12% (HR: 1.12, 95% CI: 1.04-1.21, p = 0.003). RCS analysis revealed a U-shaped association of RBC folate with all-cause, CVD, and cancer mortality, with inflection points at 540.5 ng/ml, 575.2 ng/ml, and 624.1 ng/ml, respectively. Further segmented regression showed that an increase in RBC folate reduced only cancer mortality risk to the left of the inflection points. To the right of these points, RBC folate was significantly positively associated with all-cause, CVD, and cancer mortality risks. HIGHLIGHTS: RBC folate exhibited a U-shaped association with all-cause, cardiovascular-specific, and cancer-specific mortality risks in patients with depression.
conclusionDietary and serum folate were not associated with overall mortality rates in patients with depression. However, RBC folate exhibited a U-shaped association with all-cause, cardiovascular-specific, and cancer-specific mortality risks in patients with depression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.